Indian drug maker Dr Reddy Laboratories Ltd was hit by a cyber-attack. While the exact nature of the attack is yet to be made public, it is reported that this data breach forced the firm to temporarily shut down operations of all its major manufacturing facilities across the world. The company has shared that they have 'isolated' its data centre services after a cyber-attack. The data breach occurred days after the company received regulatory approvals to conduct human trials of a COVID-19 vaccine candidate developed by a Russian research institute.